Five common pitfalls when writing a Clinical Evaluation Report

Dr Paul Hercock
Avoid pitfalls when writing a Clinical Evaluation Report

Writing a Clinical Evaluation Report (CER) is one of the most demanding aspects of preparing a medical device submission under the MDR. It calls for a comprehensive appraisal and analysis of all clinical evidence relating to the subject device, along with an objective analysis of data relating to the clinical background and comparable alternative devices.

Video 1: Five common pitfalls when writing a Clinical Evaluation Report

Needless to say, it’s common to run into difficulties when writing a CER and it’s not a task to approach lightly. Because “forewarned is forearmed”, here are five common pitfalls when writing a CER and some tips to overcome them.

Pitfall 1 - Not being ready

In some cases, manufacturers attempt to write a CER too early in a device’s developmental journey. Because a CER considers a broad range of evidence including pre-clinical bench tests, clinical evidence and PMS data, there’s little point conducting a CER until such information is available.

Having said that, it is possible to use a framework CER to act as a form of enhanced Gap Analysis by highlighting aspects of a regulatory strategy that are missing; however, using a CER this way requires an experienced eye and a very thorough CER structure.

Tip - If you are writing it yourself, it's generally better to wait until the device is more mature before attempting a Clinical Evaluation Report.

Pitfall 2 - Incorrect structure

It goes without saying that it’s vital to know what needs to be included in a CER. Difficulties can arise because requirements are dynamic, meaning that what constituted correct structure a year ago might not be sufficient today.

A common failure point is an over-reliance on outdated guidelines such as MedDev 2.7/1 rev 4 - while this was the ‘gold standard’ for many years, this has not yet been updated to reflect changes in the MDR. Furthermore, MedDev is not especially easy to work with. An optimal CER structure will account for requirements in the MDR as well as MDCG guidelines, industry standards and the aspects of MedDev that remain relevant.

Tip - Because ensuring the correct CER structure is so vital to success, we were motivated to release our unique, 64-page CER Template which provides not only the correct structure, but also includes sample text, examples and other guidance to give you line-by-line support through the entire CER-writing process.

Pitfall 3 - Not accounting for exclusions

All good CERs require an extensive review of the medical literature. In fact, done properly, a CER actually calls for two reviews - one against the subject device itself, and another against the clinical background and any comparable alternative devices. The latter is used to determine safety and performance benchmarks against which to assess the subject device.

As if performing thorough literature search & review wasn’t enough of a challenge, it’s also a requirement that you account for and justify every excluded paper for each search term you use. Needless to say, because some search terms will generate thousands of results, this can become extremely time-consuming and laborious.

Tip - It's vital that you have an effective strategy to ensure that exclusion handling is efficient and manageable, including careful search term selection and use of appropriate software.

Our team have developed a range of unique techniques that enable us to offer a market-leading literature review and exclusions service that is central to the way we deliver CERs.

Pitfall 4 - Incorrect use of language and ‘naked’ opinions

This is a pitfall that even the most experienced writers can fall into.

Tip - It's crucial that the correct type of language is adopted throughout the CER.

Ensure that an objective ‘third person’ tense is used. For example, using terms such as “we feel that this constitutes an appropriate number of complaints over a 12-month period” introduces an ‘opinion’ that has no place in an objective assessment.

Instead, use phrasing such as “There were x recorded complaints between December 2020 and December 2021. As presented in Section 1.2.3, this is numerically equivalent to rates seen for Products A, B and C which constitute comparable alternatives to the subject device.”

Always avoid opinions - especially if they are ‘naked’ - ie unsubstantiated. So “This is the most common cause of acne” would be better phrased as “Jones et al (2017) undertook a systematic review which found that x is the most common cause of acne in adolescent males”.

Pitfall 5 - Lack of objectivity

When writing a CER for your own product, this is perhaps the most difficult pitfall to avoid. The MDR calls for an objective approach with equal weighting (allowing for variances in study design and quality) given to sources that are favourable and unfavourable to the subject device. Presenting negative data against one’s own device is never comfortable or easy.

Tip - Nonetheless, avoiding or inappropriately excluding negative data is a big no-no and will inevitably lead to a non-conformity. There's no easy fix, although it's a strong argument in favour of engaging an external specialist to help with the preparation of the CER.

Summary

Video 2: See how our Clinical Evaluation Report writing service works from start to finish

Our team of medical writers are all highly qualified medical professionals, meaning they deliver the highest standards of independent objectivity alongside their peerless ability to work with clinical evidence and their unparalleled subject matter expertise.

If you’d like more information on anything related to CERs, feel free to contact our team for a no obligation discussion. Or why not come along to one of our free CER ask-me-anything clinics?

Related articles

  1. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  2. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  3. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  4. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  5. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  6. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  7. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  8. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  9. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  10. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  11. An update on UKCA Marking of Medical Devices

    UKCA Marking of Medical Devices – An update on the status quo

    We review recently updated requirements for UKCA marking and what it means for your regulatory strategy.

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  12. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  13. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  14. Literature Search, SOTA Review and Clinical Evaluation

    Literature Search, SOTA Review process and Clinical Evaluation

    We help to demystify the process of systematic search & review of literature for Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  15. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  16. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  17. How to make a medical device equivalence claim under the MDR

    Five tips for making a medical device equivalence claim under the MDR

    We'll show you what to keep in mind with regards to equivalance and Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  18. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  19. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  20. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  21. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  22. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  23. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  24. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  25. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  26. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  27. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  28. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  29. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need help with your regulatory strategy?

Talk to us